Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Healthy Returns

Recent news which mentions Healthy Returns

Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Healthy Returns Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Social issues Healthy Returns LILLY DRN
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Biotech and Pharmaceuticals Amgen Inc Health care industry
From CNBC.com News
Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say
Tags Biotech and Pharmaceuticals Healthy Returns Social issues
From CNBC.com News
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
Tags Health care industry Biotech and Pharmaceuticals Amgen Inc
From CNBC.com News
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
Tags AstraZeneca PLC Healthy Returns Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags LILLY DRN Health & Science Social issues
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Biotech and Pharmaceuticals Microsoft Corp Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Healthy Returns Abbott Laboratories Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: What activist Starboard's $1 billion stake means for Pfizer
Tags Health & Science Healthy Returns Social issues
From CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
Tags Fulcrum Therapeutics Inc Health care industry Pfizer Inc
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Tags Health care industry Health & Science Social issues
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Health & Science Healthy Returns Eli Lilly and Co
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Tags Berkshire Hathaway Inc Health & Science Social issues
From CNBC.com News
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
Tags Healthy Returns Dexcom Inc Social issues
From CNBC.com News
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
Tags Biotech and Pharmaceuticals Moderna Inc Pfizer Inc
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Pfizer Inc Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Altimmune Inc Augmedix Inc Novo Nordisk A/S
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Novartis AG AstraZeneca PLC Healthy Returns
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Gilead Sciences Inc Healthy Returns Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Science Zealand Pharma A/S Health & Science
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Health & Science Eli Lilly and Co Social issues
From CNBC.com News
Healthy Returns: What we know about the next round of Covid vaccines
Tags Health care industry Pfizer Inc Alphabet Inc
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Bristol/Myers Squibb Co Johnson & Johnson AstraZeneca PLC
From CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
Tags Pfizer Inc Merck & Co Inc Health care industry
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.